Biotin

Biotin

SCHEMBL3666882

CC(C)(C)OC(=O)NCCn1c(=O)n(C2CCN(C(=O)O)[C@H](N(Cc3ccccc3)Cc3ccccc3)C2CCCc2ccccc2)c2ccccc21.NCCn1c(=O)n(C2CCN(C(=O)O)[C@H](N(Cc3ccccc3)Cc3ccccc3)C2CCCc2ccccc2)c2ccccc21.O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 7/20 0.39
▸ CA1 P00915 7/20 0.39
▸ CA2 P00918 7/20 0.39
▸ CA9 Q16790 7/20 0.39
▸ SLC6A3 Q01959 2/20 0.38
▸ PSEN1 P49768 2/20 0.36
▸ PSEN2 P49810 2/20 0.36
▸ APH1B Q8WW43 2/20 0.36
▸ NCSTN Q92542 2/20 0.36
▸ APH1A Q96BI3 2/20 0.36
▸ PSENEN Q9NZ42 2/20 0.36
▸ FOLH1 Q04609 1/20 0.36
▸ TDP1 Q9NUW8 3/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ IDE P14735 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biotin SCHEMBL3668898 0.91 CA12 (0.45) CA12CA1CA2CA9SLC6A3
SCHEMBL3811734 0.84 SIGMAR1 (0.41) F2PRSS1
Biotin SCHEMBL4676277 0.83 PSEN1 (0.33) CA12CA1CA2CA9SLC6A3
SCHEMBL4736833 0.80 CACNA1G (0.44) —
SCHEMBL3667025 0.76 CACNA1G (0.36) F2PRSS1
SCHEMBL3811730 0.72 SIGMAR1 (0.36) —
Biotin SCHEMBL3667448 0.72 TDP1 (0.52) CA12CA1CA2CA9SLC6A3
SCHEMBL3721849 0.71 CACNA1G (0.42) MEN1LMNAKMT2ASLC18A3
SCHEMBL1832947 0.69 CACNA1G (0.38) MEN1LMNAKMT2ASLC18A3
Biotin SCHEMBL3742251 0.69 CA12 (0.41) CA12CA1CA2CA9SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback